文献速递主动脉疾病

顺行腔内移植物释放联合主动脉上分支去分支化治疗主动脉弓及降胸主动脉病变的单中心经验

Antegrade Endograft Deployment with Supra-Aortic Debranching to Treat Arch and Descending Thoracic Aortic Lesions. A Single-Center Experience.
PubMed 文献 · Ann Vasc Surg · 2022-04-05

该单中心回顾性分析评估了主动脉上分支去分支化联合顺行胸主动脉腔内修复(TEVAR)的效果,2005年12月至2017年4月共55例患者接受64次TEVAR,其中8例男性(平均年龄72岁)行顺行支架释放联合去分支化。30天死亡率为12.5%,1例暂时性右偏瘫经左颈动脉-颈动脉旁路后缓解,术后及随访无内漏,平均随访4.9年无支架或血运重建相关死亡。作者认为该技术对复杂不良解剖是安全的治疗方式,但因神经并发症和再干预存在,建议进一步改进。

要点

  • 8例患者行顺行TEVAR联合主动脉上分支去分支化,30天死亡率为12.5%。
  • 术后及随访无内漏,平均随访4.9年无支架或血运重建相关死亡。
  • 作者认为该技术对复杂不良解剖是安全治疗方式,但因神经并发症和再干预建议进一步改进。

核心结论

  • 顺行释放腔内移植物联合主动脉上血管的杂交与血运重建手术,在复杂不良解剖中是安全的治疗方式。
  • 由于存在神经并发症和再干预,建议进一步改进。

研究设计与样本

  • 单中心回顾性分析,评估顺行TEVAR期间主动脉上分支去分支化的有效性。
  • 2005年12月至2017年4月,55例患者共接受64次TEVAR,其中8例男性(平均年龄72岁)行杂交顺行支架释放。

主要发现

  • 8例手术指征:退行性主动脉弓动脉瘤3例、降胸主动脉瘤3例、创伤后假性动脉瘤1例、穿透性主动脉溃疡导致主动脉食管瘘1例。
  • 近端锚定区:Z0为1例、Z1为3例、Z2为4例;I型杂交主动脉弓修复1例、颈动脉-颈动脉旁路2例、颈动脉-锁骨下动脉旁路5例、主动脉-颈动脉旁路1例。
  • 30天术后死亡率为12.5%;1例出现暂时性右偏瘫,经左主动脉-颈动脉旁路后缓解。
  • 术后及随访期间未观察到内漏;平均随访4.9年,无与支架植入或血运重建手术相关的死亡。
  • 关于主动脉弓改道手术,未出现假性动脉瘤或其他吻合口事件。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Thoracic endovascular aortic repair (TEVAR) is a widely used procedure that has drastically changed the management of thoracic aortic diseases. We assess the effectiveness of supra-aortic debranching during antegrade TEVAR procedures with a retrospective analysis of our clinical experience. METHODS: Between December 2005 and April 2017, 55 patients underwent 64 TEVAR procedures. Among them, there were 8 male patients, mean age 72, who underwent hybrid antegrade stent-graft deployment. Particularly, for degenerative aneurysms of the aortic arch, 3 patients for aneurysm of descending thoracic aorta 3, for post-traumatic pseudoaneurysm 1, and for penetrating aortic ulcer 1 which had resulted in an aortoesophageal fistula. Proximal landing zones were Z0:1, Z1:3 and Z2:4. Type I hybrid aortic arch repair was performed in 1 case, carotid-carotid bypass in 2, carotid-subclavian in 5 and aorto-carotid in 1. RESULTS: The 30-day postoperative mortality was 12.5%. One patient suffered a temporary right hemiplegia which resolved after left aorto-carotid bypass. No endoleaks were observed postoperatively and in follow-up period. In the long term and a mean follow-up of 4.9 years, there were no deaths related to the stent-graft implantation or to revascularization procedures. Regarding the aortic arch rerouting procedure, there were no pseudoaneurysm or other anastomotic events. CONCLUSIONS: Antegrade delivery of the endograft, combined with hybrid and revascularization procedures of the supra-aortic vessels is a safe treatment modality, in complex hostile anatomies. However, further improvements are recommended due to the presence of neurologic complications and reinterventions.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Eforakopoulos F, Koletsis E, Moulakakis KG, et al. Antegrade Endograft Deployment with Supra-Aortic Debranching to Treat Arch and Descending Thoracic Aortic Lesions. A Single-Center Experience. Ann Vasc Surg. 2022. PMID: 35395374. doi:10.1016/j.avsg.2022.03.023

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。